CSI Market
Sign In | Register

Xtl Biopharmaceuticals Ltd (XTLB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access XTLB Annual Balance Sheets →
This page allows investors to track Xtl Biopharmaceuticals Ltd's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Aug 14 2024) (Dec 31 2023) 0 0
Assets
Cash And Cash Equivalents0.37
Cash & Short-term Investments0.00
Accounts receivable0.10
Other Current Assets0.00
Total Current Assets1.34
Equipment/Property/Plant Net0.19
Goodwill net3.19
Intangible Assets3.82
Other Assets, Noncurrent0.00
Total Assets8.55
Liabilities
Accounts Payable0.00
Total Current Liabilities2.21
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Total Liabilities3.12
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity5.44
Total Stockholder's Equity5.44
Liabilities & Stockholder's Equity8.55
4 historic quarters locked

Sign in to unlock the full Xtl Biopharmaceuticals Ltd balance sheet history.

Sign In Create Free Account

About Xtl Biopharmaceuticals Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-073831

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.